My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1880

    1.

    The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program.

    Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME; Diabetes Prevention Program Research Group.

    Diabetes Care. 2006 Apr;29(4):914-9.PMID: 16567837 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

    Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H; Diabetes Prevention Program Research Group.

    Diabetes. 2005 Aug;54(8):2404-14.PMID: 16046308 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

    Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R; Diabetes Prevention Program.

    Diabetes. 2008 Apr;57(4):980-6. Epub 2008 Jan 11.PMID: 18192541 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

    Eddy DM, Schlessinger L, Kahn R.

    Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.

    Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ.

    Clin Ther. 2004 Feb;26(2):304-21.PMID: 15038953 [PubMed - indexed for MEDLINE]Related articles

    6.

    The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.

    Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R.

    J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1075-81.PMID: 17077202 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children.

    Chessa M, Butera G, Lanza GA, Bossone E, Delogu A, De Rosa G, Marietti G, Rosti L, Carminati M.

    Herz. 2002 Dec;27(8):785-90.PMID: 12574897 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998.

    Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D.

    Circulation. 2003 May 6;107(17):2190-5. Epub 2003 Apr 14.PMID: 12695289 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

    Crandall JP, Polsky S, Howard AA, Perreault L, Bray GA, Barrett-Connor E, Brown-Friday J, Whittington T, Foo S, Ma Y, Edelstein SL; Diabetes Prevention Program Research Group.

    Am J Clin Nutr. 2009 Sep;90(3):595-601. Epub 2009 Jul 29.PMID: 19640960 [PubMed - indexed for MEDLINE]Related articles

    10.

    Relationship of body size and shape to the development of diabetes in the diabetes prevention program.

    [No authors listed]

    Obesity (Silver Spring). 2006 Nov;14(11):2107-17.PMID: 17135629 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study.

    Carnethon MR, Jacobs DR Jr, Sidney S, Liu K; CARDIA study.

    Diabetes Care. 2003 Nov;26(11):3035-41.PMID: 14578236 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.

    Diabetes Prevention Program Research Group.

    Diabetes Care. 2003 Sep;26(9):2518-23.PMID: 12941712 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of supervised integrated exercise on heart rate variability in type 2 diabetes mellitus.

    Bhagyalakshmi S, Nagaraja H, Anupama B, Ramesh B, Prabha A, Niranjan M, Shreedhara A.

    Kardiol Pol. 2007 Apr;65(4):363-8; discussion 369.PMID: 17530559 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

    Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC; Diabetes Prevention Program Research Group.

    Diabetes Care. 2008 Mar;31(3):420-6. Epub 2007 Dec 10.PMID: 18071002 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study.

    Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G.

    Diabetes. 2002 Dec;51(12):3524-31.PMID: 12453910 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program.

    West DS, Elaine Prewitt T, Bursac Z, Felix HC.

    Obesity (Silver Spring). 2008 Jun;16(6):1413-20. Epub 2008 Apr 10.PMID: 18421273 [PubMed - indexed for MEDLINE]Related articles

    17.

    Body size and shape changes and the risk of diabetes in the diabetes prevention program.

    Fujimoto WY, Jablonski KA, Bray GA, Kriska A, Barrett-Connor E, Haffner S, Hanson R, Hill JO, Hubbard V, Stamm E, Pi-Sunyer FX; Diabetes Prevention Program Research Group.

    Diabetes. 2007 Jun;56(6):1680-5. Epub 2007 Mar 15.PMID: 17363740 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation.

    Wakabayashi S, Aso Y.

    Diabetes Care. 2004 Oct;27(10):2392-7.PMID: 15451906 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Regular physical exercise, heart rate variability and turbulence in a 6-year randomized controlled trial in middle-aged men: the DNASCO study.

    Tuomainen P, Peuhkurinen K, Kettunen R, Rauramaa R.

    Life Sci. 2005 Oct 7;77(21):2723-34.PMID: 15978638 [PubMed - indexed for MEDLINE]Related articles

    20.

    The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.

    Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

    Diabetologia. 2007 Dec;50(12):2451-60. Epub 2007 Sep 27.PMID: 17898990 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity